HealthAI imageDr Reddy’s launches Nivorz, Opdivo biosimilar in India
Dr Reddy’s Laboratories has launched Nivorz, a biosimilar version of Bristol Myers Squibb's Opdivo (nivolumab), in India. Approved by the Drugs Controller General of India (DCGI), Nivorz covers 12 cancer indications including solid tumors and blood cancers, marking Dr Reddy’s entry into the immuno-oncology segment.
Moneycontrol·


